The invention provides mitochondrially targeted antioxidant compounds. A compound of the invention comprises a lipophilic cation covalently coupled to an antioxidant moiety. In preferred embodiments, the lipophilic cation is the triphenyl phosphonium cation, and the compound is of the formula P(Ph
3
)
+
XR.Z
−
where X is a linking group, Z is an anion and R is an antioxidant moiety. Also provided are pharmaceutical compositions containing the mitochondrially targeted antioxidant compounds, and methods of therapy or prophylaxis of patients who would benefit from reduced oxidative stress, which comprise the step of administering the compounds of the invention.
本发明提供线粒体靶向抗氧化化合物。本发明的化合物包括与
抗氧化剂分子共价偶联的亲脂阳离子。在优选的实施方案中,亲脂阳离子是三苯基
鏻阳离子,化合物的
化学式为 P(Ph
3
)
+
XR.Z
-
其中 X 是连接基团,Z 是阴离子,R 是
抗氧化剂分子。此外,还提供了含有线粒体靶向
抗氧化剂化合物的药物组合物,以及治疗或预防可从降低氧化应激中获益的患者的方法,其中包括施用本发明化合物的步骤。